Trump administration order denies student loan relief to nonprofit workers engaged in ‘improper’ activity

US President Donald Trump has announced significant changes to the Public Service Loan Forgiveness program, a move that could impact thousands of borrowers. Since returning to office, Trump has taken a hard stance on various policies, including education, immigration, and loan forgiveness, signaling a shift in federal priorities.In the latest development, the administration signed an…

Read More

‘Enough of our own domestic affairs, but …’: Putin thanks PM Modi, Trump for efforts to stop Russia-Ukraine war | India News

NEW DELHI: Russian President Vladimir Putin on Thursday thanked Prime Minister Narendra Modi, US President Donald Trump and Brazil President Luiz Inacio Lula da Silva for their efforts to end the ongoing Russia-Ukraine conflictIn his first public reaction on Ukraine’s willingness to negotiate a ceasefire, Putin said that he agrees with the proposal of ceasefire…

Read More

Aries, Daily Horoscope Today, March 13, 2025: Family interactions will be pleasant

Today brings success and accomplishment across various life aspects for Aries. A renewed sense of confidence and enthusiasm will be evident in actions and decisions. Social gatherings and family functions bring joy. Business expansion opportunities arise during long journeys. Health, career progress, and financial stability are favorable, with minor misunderstandings in relationships to be navigated…

Read More

‘ICE will flood Sanctuary cities’: Trump’s Border czar Tom Homan warns New York Governor Kathy Hochul

Tom Homan and Gov. Hochul (AP) US President Donald Trump’s border czar, Tom Homan on Wednesday warned migrant “sanctuary” jurisdictions, urging them to “get out of the way” or face an increased presence of “exactly what they don’t want, more ICE agents in the community.”While visiting the New York state Capitol, Homan criticised Gov. Kathy…

Read More

Sun Pharma to acquire US oncology compony for over Rs 3,000 crore

Sun Pharma, India’s largest drugmaker, is acquiring Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and targeted oncology company, for $355 million (over Rs 3,000 crore).The acquisition will bolster the company’s specialty portfolio.Checkpoint is a commercial-stage company that develops novel treatments for patients with solid tumor cancers, and the acquisition includes UNLOXCYT, an FDA-approved treatment for advanced skin…

Read More